About • Project Farma

Who We Are

We provide biomanufacturing strategy and execution to startup and established pharmaceutical companies, advanced therapy companies, academia, hospitals, government agencies, financial institutions, CROs/CMOs, not-for-profit organizations and medical device companies. Our services include turnkey capital projects, tech transfers and facility builds; owner's representation; project and program management; validation; quality, regulatory and compliance; engineering and automation; serialization / track and trace; reliability, compliance and asset management; and more. We are committed to advancing manufacturing to achieve operational excellence and accelerate speed to market for next-generation medicines.

Our Global Footprint

We provide support globally and are currently supporting projects in: Asia, Australia, Europe, Middle East and North America.

Our corporate headquarters is located in Bethesda, MD and we provide regional support across the United States. We are currently supporting projects in: California, Colorado, Delaware, Florida, Maryland, Massachusetts, Minnesota, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Texas, Utah, Washington D.C., and Wisconsin.

Philanthropy is Built
into our Foundation

As a patient-focused delivery team, we are committed to connecting our team members to patients and their families. Connecting our team to the patients has fostered a culture within our organization that is focused on providing solutions, meeting deadlines and getting results.

Learn More

Anshul founded and steered PF to become a prominent global consultancy specializing in biologics and advanced therapy engineering with 200+ professionals. Anshul’s role extends to overseeing all corporate legal matters as General Counsel. Under Anshul’s guidance, PF pioneered the industrialization of groundbreaking therapeutics, including some of the earliest commercially approved cell and gene therapies, radioligand treatments, RNA-based therapies, and cutting-edge biologics. Additionally, Anshul led PF in acquiring and conducting due diligence on other engineering consulting firms, bolstering the company’s ability to offer comprehensive solutions to drug developers facing manufacturing and technical challenges. PF’s recent achievements include leading 50+ facility builds with a total capital investment exceeding $5 billion, managing 200+ capital projects, and collaborating with 100+ life science companies.

In 2020, Precision Medicine Group acquired PF, making it the cornerstone of Precision ADVANCE. ADVANCE is a collection of services within Precision, uniquely focused on addressing the intricate aspects of research, clinical development, regulatory compliance, manufacturing, and commercialization required to successfully bring complex, innovative therapies to market. Anshul’s commitment to advancing next-generation medicines extends to various boards and philanthropic organizations, including IQHQ, Alliance for Regenerative Medicines, Alliance for mRNA Medicines, Institute for Life Changing Medicines and several patient-advocacy organizations.

Before his tenure at PF, Anshul was an attorney and founded several digital agencies. He was a patent litigator at Jones Day and dedicated pro bono work to help persecuted refugees attain asylum in the United States. He graduated from Purdue University with a Bachelor’s in Computer and Electrical Engineering and earned his law degree from John Marshall Law School. During law school, he clerked for a federal judge in the Northern District of Illinois and was Editor-in-Chief of the Review of Intellectual Property Law.

James Burback is a highly accomplished Director at Project Farma, leveraging his extensive experience and passion for people to lead high-performing teams. With over 15 years of expertise in the Biotech industries, James possesses a deep understanding of continuous improvement planning and implementation, enabling him to drive projects towards successful completion.

James excels at fostering a culture of curiosity, encouraging his teams to ask important questions and effectively communicate unmet needs within projects. By doing so, he facilitates the efficient and timely execution of each project, always mindful of scope, schedule, and budget. As a versatile leader, James provides high-level technical direction and collaborates seamlessly with cross-functional teams throughout the product life cycle, ensuring the full realization of goals for both Project Farma and its global life science partners.

Drawing from his extensive background in manufacturing, James possesses a unique perspective on the impact of even the smallest decisions on the individuals involved in the production process. This valuable insight, combined with his expertise in implementing data integrity solutions, allows him to develop and execute strategic and tactical initiatives that enhance production, elevate quality, and reduce costs.

James holds a Master’s degree in Biochemistry from Colorado State University, solidifying his academic foundation and further enhancing his capabilities as a dynamic leader. With his exceptional skill set, dedication to continuous improvement, and unwavering commitment to team success, James Burback continues to make significant contributions within the biotech industry.